Financials

  • Market Capitalization 22 M
  • Employee 115
  • Founded 1998
  • CEO N/A
  • Website www.celularity.com
  • Headquarter Delaware, United States
  • FIGI BBG00P2RTT34
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-0.31
Price to sales ratio
1.07

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
4564
NRSN
NeuroSense Therapeutics Ltd. - Ordinary Shares
0.72 USD-1.37%+4.35%-4.00%-64.00%23.44 M USD
4588
KZIA
Kazia Therapeutics Limited - American Depositary Shares
13.48 USD-0.81%+5.97%-7.42%+130.43%21.82 M USD
4592
ALGS
Aligos Therapeutics, Inc. - Common stock
6.42 USD+0.94%+6.82%+21.13%-34.42%22.24 M USD
4595
VYNE
VYNE Therapeutics Inc. - Common Stock
0.71 USD+7.58%+5.97%+9.23%-46.21%23.68 M USD

Frequently asked questions about Celularity Inc. - Class A Common Stock

What is the Celularity Inc. - Class A Common Stock stock price today?

The current price of Celularity Inc. - Class A Common Stock (CELU) is 0.76. Over the past 24 hours, the stock has changed by 0.00%. Follow the CELU chart for real-time price dynamics.

What is the stock ticker of Celularity Inc. - Class A Common Stock?

Celularity Inc. - Class A Common Stock trades under the ticker CELU. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Celularity Inc. - Class A Common Stock stock going up?

CELU has changed by +4.11% over the last week, -5.00% over the last month, and -68.60% over the last year. Review the chart to see whether the current move is part of a broader trend.

What was Celularity Inc. - Class A Common Stock net income for the last quarter?

Celularity Inc. - Class A Common Stock reported net income of -24.36 M for the last quarter. The previous quarter showed -23.08 M, which means net income changed by -5.57%.

How many employees does Celularity Inc. - Class A Common Stock have?

As of the latest available data, Celularity Inc. - Class A Common Stock has 115 employees. Workforce size can provide additional context about the company's scale and operations.

What is Celularity Inc. - Class A Common Stock EBITDA?

Celularity Inc. - Class A Common Stock EBITDA is -23.25 M, and its EBITDA margin is -566.54%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Celularity Inc. - Class A Common Stock stock?

You can buy Celularity Inc. - Class A Common Stock (CELU) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Celularity Inc. - Class A Common Stock stock?

Investing in Celularity Inc. - Class A Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the CELU chart and related analysis on metatrader.com as part of your research.

News